LAPPANO, Rosamaria
 Distribuzione geografica
Continente #
EU - Europa 4.558
NA - Nord America 3.413
AS - Asia 828
AF - Africa 158
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
SA - Sud America 5
Totale 8.978
Nazione #
US - Stati Uniti d'America 3.355
RU - Federazione Russa 2.295
UA - Ucraina 704
IT - Italia 418
DE - Germania 389
CN - Cina 325
AT - Austria 315
SG - Singapore 310
SE - Svezia 192
SN - Senegal 157
TR - Turchia 82
FI - Finlandia 65
CA - Canada 50
GB - Regno Unito 37
IN - India 36
NL - Olanda 35
BE - Belgio 31
FR - Francia 31
KR - Corea 30
CZ - Repubblica Ceca 26
HK - Hong Kong 23
AU - Australia 8
EU - Europa 8
IE - Irlanda 8
AZ - Azerbaigian 3
IR - Iran 3
JM - Giamaica 3
MX - Messico 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BR - Brasile 2
BY - Bielorussia 2
EC - Ecuador 2
EE - Estonia 2
HU - Ungheria 2
JP - Giappone 2
BD - Bangladesh 1
BG - Bulgaria 1
CH - Svizzera 1
CR - Costa Rica 1
IQ - Iraq 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MS - Montserrat 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
QA - Qatar 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 8.978
Città #
Moscow 2.292
Chandler 636
Jacksonville 383
Boardman 293
San Mateo 269
Singapore 244
Vienna 229
Dearborn 202
Dakar 157
New York 157
Ashburn 119
Lawrence 102
Roxbury 99
Rende 96
Shanghai 94
Izmir 77
Des Moines 66
Florence 56
Helsinki 55
Brooklyn 53
Ann Arbor 47
Ottawa 41
Beijing 37
Wilmington 34
Inglewood 32
Munich 32
Seattle 32
Ogden 31
Brussels 30
Seoul 30
Bremen 27
Brno 26
Hong Kong 18
Cambridge 16
Houston 16
Bari 15
Cosenza 14
Guangzhou 14
Los Angeles 14
Redmond 14
Redwood City 14
San Francisco 14
Grafing 11
Pune 10
Amantea 9
Wuhan 9
Dublin 8
Falls Church 8
Kilburn 8
Palermo 8
Catanzaro 7
Edinburgh 7
Espoo 7
Toronto 7
Chicago 6
Jiaxing 6
Jinhua 6
Norwalk 6
Quanzhou 6
Carovigno 5
Catania 5
Frankfurt am Main 5
Nanjing 5
Paris 5
Rome 5
Barnsley 4
Berlin 4
Changsha 4
Hebei 4
London 4
Vibo Valentia 4
Yiwu 4
Amsterdam 3
Baku 3
Canberra 3
Central 3
Hamburg 3
Heze 3
Jinan 3
Kunming 3
Lamézia 3
Lappeenranta 3
Nantes 3
Nocera Terinese 3
Olgiate Olona 3
Princeton 3
Riyadh 3
Scalea 3
Shenzhen 3
Sittard 3
Sydney 3
Utrecht 3
Ahmedabad 2
Almere Stad 2
Aversa 2
Boydton 2
Cappelle sul Tavo 2
Chennai 2
Como 2
Crotone 2
Totale 6.490
Nome #
c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells 2.365
Crystallographic snapshots of host–guest interactions in drugs@metal–organic frameworks: towards mimicking molecular recognition processes 141
(6-Bromo-1,4-dimethyl-9H-carbazol-3-yl-methylene)-hydrazine (Carbhydraz) Acts as a GPER Agonist in Breast Cancer Cells 133
GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells Toward Breast Tumor Progression 119
Functional characterization of the partially purified Sac1p-independent adenine nucleotide transport system (ANTS) from yeast endoplasmic reticulum 118
Copper activates HIF-1α/GPER/VEGF signalling in cancer cells 114
Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells 114
GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts 111
AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs) 110
Computational Approaches for the Discovery of GPER Targeting Compounds 104
Bisphenol A Induces Gene Expression Changes and Proliferative Effects through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts 102
E-cadherin mediates the aggregation of breast cancer cells induced by tamoxifen and epidermal growth factor 98
Carbazole derivatives as potential novel agonist of GPER 97
Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells 94
In vitro antiproliferative and proapoptotic activities of 2-oxazolidinone derivatives 91
DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop 90
miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs) 89
A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: mechanisms and models. 88
Composition, Antifungal and Antiproliferative Activities of the Hydrodistilled Oils from Leaves and Flower Heads of Pterocephalus nestorianus Nab. 86
miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling 84
A Biocompatible Aspartic-Decorated Metal-Organic Framework with Tubular Motif Degradable under Physiological Conditions 82
Identification of novel estrogen-regulated microRNAs in breast tumor cells and cancer-associated fibroblasts (CAFS) 81
G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells 80
The lauric acid-activated signaling prompts apoptosis in cancer cells 80
Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression 80
Estrogenic Gper-signaling triggers RERG expression in breast cancer cells and cancer-associated fibroblasts 77
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer 76
GPER mediates activation of HIF1α/VEGF signaling by estrogens 75
GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells 75
HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs) 75
Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets 75
G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17β-estradiol in cancer cells and cancer-associated fibroblasts 73
Glycerophospholipid synthesis as a novel drug target against cancer 73
A Bodipy as a luminescent probe for detection of the G protein estrogen receptor (GPER) 72
The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis 72
A sexually dimorphic distribution pattern of the novel estrogen receptor G-protein coupled receptor 30 in some brain areas of the hamster 69
The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells 68
IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells 68
GPER is involved in the regulation of the estrogen-metabolizing CYP1B1 enzyme in breast cancer 67
Ddr1 affects metabolic reprogramming in breast cancer cells by cross-talking to the insulin/igf system 67
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer 66
HYPOXIA PROMOTES TUBULAR INJURY VIA THE ACTIVATION OF THE ESTROGENIC RECEPTOR GPER AND P75(NTR) 66
Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer‐associated fibroblasts 66
SLC37A1 Gene expression is up-regulated by epidermal growth factor in breast cancer cells 65
Epidermal growth factor up-regulates SLC37A1 gene expression in cancer cells. 64
MIBE acts as antagonist ligand of both estrogen receptor alpha and GPER in breast cancer cells 64
Recent Advances in the Rationale Design of GPER Ligands. 63
GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response 63
A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer 63
G protein-coupled receptor 30 expression is up-regulated by EGF and TGFalpha in estrogen receptor alpha-positive cancer cells 62
GPCR modulation in breast cancer 60
The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs) 60
Cross-talk between GPER and growth factor signaling 59
Different 6-Aryl-Fulvenes exert anti-proliferative effects on Cancer Cells 58
GPER Function in Breast Cancer: An Overview 58
Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells 58
Two Novel GPER Agonists Induce Gene Expression Changes and Growth Effects in Cancer Cells. 57
Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC) 56
Multifactorial Regulation of GPER Expression in Cancer Cells and Cardiomyocytes 56
IGF-I/IGF-IR Transduction System Involves GPER and DDR1 in the Stimulation of Mesothelioma and Lung Cancer Cells 56
The cholesterol metabolite 25-Hydroxycholesterol activates estrogen receptor α-Mediated signaling in cancer cells and in cardiomyocytes 56
Tamoxifen and epidermal growth factor induce the aggregation of MCF7 breast cancer cells up-regulating E-cadherin expression 56
Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer 55
New titanocene derivatives with high antiproliferative activity against breast cancer cells 53
Newly Synthesized Imino-Derivatives Analogues of Resveratrol Exert Inhibitory Effects in Breast Tumor Cells 53
Structure-activity relationships of resveratrol and derivatives in breast cancer cells 52
RUOLO DEL RECETTORE p75NTR E DEL RECETTORE ESTROGENICO GPER NEL DANNO IPOSSICO TUBULARE 52
The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells 52
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells 51
Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling 51
GPCRs and cancer 50
The Novel Estrogen Receptor GPR30 Mediates the Proliferative Effects Induced by 17beta-Estradiol on GC-1 Mouse Spermatogonial Cell Line 50
Recent advances on the stimulatory effects of metals in breast cancer 50
Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells 50
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 49
Insulin-like growth factor-I regulates GPER expression and function in cancer cells 49
Effects of Atrazine on Estrogen Receptor α- and G Protein-Coupled Receptor 30-Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts 49
Structure-Based Approach for the Discovery of Novel Selective Estrogen Receptor Modulators RID D-5386-2011 49
The novel estrogen receptor GRP30 mediates the proliferatiive effects induced by 17beta-estradiol onGC-1 mouse spermatogonial cell line 48
Organo-Metallic Compounds: Novel Molecules in Cancer Therapy 47
Macromolecular Modelling and Docking Simulations for the Discovery of Selective GPER Ligands. 47
G protein-coupled receptors: novel targets for drug discovery in cancer 46
GPER is involved in the regulation of CYP1b1 expression in breast cancer cells and CAFs 44
The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17β-estradiol on mouse spermatogonial GC-1 cell line 44
RUOLO DEL NUOVO RECETTORE ESTROGENICO GPER E DELL'ASSE NGF/TRKA/P75NTR NEL DANNO IPOSSICO TUBULARE RENALE 44
Niacin activates the G protein estrogen receptor (GPER)-mediated signalling 43
Novel Mechanisms Involved in the Stimulatory Effects Exerted by Zinc in Breast Cancer Cells 42
New metallorganic complexes of groups 3 and 4 as anticancer agents: Possible alterative to cis-platin. 42
Regulation of SLC37A1 gene expression by epidermal growth factor in breast cancer cells 41
The Physiopathological Role of the Exchangers Belonging to the SLC37 Family 41
Synthesis, characterization and cytotoxic activity on breast cancer cells of new half-titanocene derivatives 40
ESTROGENIC GPR30 SIGNALLING INDUCES PROLIFERATION AND MIGRATION OF BREAST CANCER CELLS THROUGH CTGF 40
Interaction of the Anti-Proliferative GPER Inverse Agonist ERα17p with the Breast Cancer Cell Plasma Membrane: From Biophysics to Biology 39
A Review on the Antimicrobial Activity of Schiff Bases: Data Collection and Recent Studies 39
New titanocene derivatives: synthesis and cytotoxic activity. 38
Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts. 38
Response to "Comment on 'Effects of Atrazine on Estrogen Receptor 〈- and G Protein-Coupled Receptor 30-Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts'". 36
Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action 35
GPER is involved in the functional liaison between breast tumor cells and cancer-associated fibroblasts (CAFs) 35
GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway 29
Totale 8.878
Categoria #
all - tutte 50.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.700


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020601 0 0 0 0 55 209 64 92 36 20 91 34
2020/2021726 98 5 86 97 14 90 20 121 37 88 5 65
2021/20221.296 6 221 12 85 135 31 14 306 16 16 166 288
2022/20231.703 211 218 76 232 178 139 9 242 172 45 115 66
2023/20242.407 153 69 80 30 55 367 432 426 99 200 162 334
2024/20251.802 554 509 355 318 66 0 0 0 0 0 0 0
Totale 9.180